Actinic keratosis as a marker of field cancerization in excision specimens of cutaneous malignancies.

Field cancerization is the process in which a singular cell accumulates genetic mutations following carcinogen exposure and then divides to create a "field" of monoclonal premalignant cells. In this study, microscopically identified actinic keratoses (AKs) were used as markers of field cancerization in all excision specimens of squamous cell carcinomas (SCCs), basal cell carcinomas (BCCs), and malignant melanomas (MMs) received by our institution's dermatopathology department over a 3- to 6-month period. Our findings provide additional evidence for the theory of field cancerization, its association with cutaneous malignancies, and the need to assess the extent of field damage when determining treatment strategies.

[1]  P Calzavara-Pinton,et al.  Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[3]  A. Ziegler,et al.  Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. , 1996, The journal of investigative dermatology. Symposium proceedings.

[4]  C. Cockerell,et al.  Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). , 2000, Journal of the American Academy of Dermatology.

[5]  M. Kripke,et al.  Mechanisms underlying UV‐induced immune suppression: implications for sunscreen design , 2002, Experimental dermatology.

[6]  R. Tarone,et al.  Frequent clones of p53-mutated keratinocytes in normal human skin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  F. D. de Gruijl.  Photocarcinogenesis: UVA vs UVB. , 2000, Methods in enzymology.

[8]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[9]  T. Jacks,et al.  Sunburn and p53 in the onset of skin cancer , 1994, Nature.

[10]  J. Mones,et al.  Solar (actinic) keratosis is squamous cell carcinoma , 2006, The British journal of dermatology.

[11]  Susan A. Cole,et al.  Field , 2018, The Body Wars.

[12]  M. Spitz,et al.  p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. , 1995, Cancer research.

[13]  L. Torezan,et al.  Cutaneous field cancerization: clinical, histopathological and therapeutic aspects* , 2013, Anais brasileiros de dermatologia.

[14]  C. R. Leemans,et al.  Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  R H Hruban,et al.  Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.

[16]  R. Stern,et al.  p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization. , 2002, The Journal of investigative dermatology.